Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Increased risk for depression persists for years among women treated for gynecological cancers: a register-based cohort study with up to 19 years of follow-up

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Gemcitabine for recurrent ovarian cancer - a systematic review and meta-analysis

    Research output: Contribution to journalReviewResearchpeer-review

  2. Nine-valent HPV vaccine efficacy against related diseases and definitive therapy: comparison with historic placebo population

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. The prognostic value of p16 and p53 expression for survival after vulvar cancer: A systematic review and meta-analysis

    Research output: Contribution to journalReviewResearchpeer-review

  1. Shared heritability and functional enrichment across six solid cancers

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Risk of CIN2+ following a diagnosis of genital warts: a nationwide cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Risk of breast cancer among women with benign ovarian tumors: a Danish nationwide cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Community-based football in men with prostate cancer: 1-year follow-up on a pragmatic, multicentre randomised controlled trial

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

OBJECTIVE: Little is known about long-term risk of depression in women treated for gynecological cancers. We aim to investigate risk for depression among these women compared to women without a history of cancer.

METHODS: We followed 16,833 women diagnosed with gynecological cancers between 1998 and 2013 and 138,888 reference women in nationwide registers for up to 19 years. Women with a history of severe psychiatric disorders, and those who had redeemed a prescription for antidepressants three years before study entry were excluded from analyses. Regression analyses were applied to compare the risk for antidepressant use among patients compared to reference women, and to investigate associations between socio-demographic as well as clinical risk factors and use of antidepressants.

RESULTS: We found an increased risk for antidepressant use among women treated for ovarian (HR 4.14, 95% CI 3.74-4.59), endometrial (HR 2.19, 95% CI 1.97-2.45), and cervical cancer (HR 3.14, 95% CI 2.74-3.61) one year after diagnosis. This increased risk persisted years after diagnosis in all three groups, with the longest (up to eight years) found for ovarian cancer. Advanced disease was strongly associated with antidepressant use followed by short education, and comorbidity.

CONCLUSIONS: Women diagnosed with gynecological cancer have an increased risk for depression compared to reference women. The risk remains increased for years after diagnosis throughout and beyond standard oncological follow-up care. Advanced disease, short education, and comorbidity are factors associated with antidepressant use in this patient group.

Original languageEnglish
JournalGynecologic Oncology
Volume153
Issue number3
Pages (from-to)625-632
Number of pages8
ISSN0090-8258
DOIs
Publication statusPublished - Jun 2019

ID: 57382539